Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in Acute Coronary Syndrome
NCT03515304Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2018
- Primary completion
- Oct 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of evolocumab in non-ST segment elevation myocardial infarction (NSTEMI), sponsored by Johns Hopkins University. Started May 2018; status: completed.
02
Drugs
evolocumab
03
Conditions
non-ST segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT03515304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03515304.